Par ships Lotrel, Rythmol SR generics
Par Pharmaceutical Companies Inc. has begun marketing generic versions of the antihypertensive Lotrel and the antiarrhythmic drug Rythmol SR.
Supplier News
CHPA names government affairs chief
The Consumer Healthcare Products Association (CHPA) has appointed Bill Head as vice president of government affairs.
Helen of Troy wraps up Kaz acquisition
Helen of Troy Ltd. has finalized its deal to acquire health care and home products manufacturer Kaz Inc. The company said Monday that sales of Kaz products are expected to top $400 for the 12 months ending Dec. 31, 2011. "We are very pleased to announce the closing of the acquisition
Combe sells cough/cold, skin care, foot care units
Combe Inc. has completed the sale of its cough and cold, skin care and foot care businesses to Reckitt Benckiser Inc. and Blistex Inc.
Mars rolls out Snickers Peanut Butter Squared
Mars Chocolate North America has shipped a new variety of its Snickers candy bar, Snickers Peanut Butter Squared, to drug stores and other mass retailers nationwide.
SC Johnson offers to buy Sara Lee shoe care business
Sara Lee Corp. has received an offer from SC Johnson to acquire Sara Lee’s global shoe care business, including the venerable Kiwi brand, for 245 million euros ($327.9 million). Sara Lee said Monday that the binding offer also includes the Kiwi Kleen, Bama, Tana and Meltonian brands.
ECRM sheds light on retail promotions
ECRM has launched a series of reports and a blog that examine retail circular advertising. The new resources are designed to provide a unique perspective on retail promotions from more than 160 retailers in the United States and Canada.
Endo set to ship Fortesta testosterone gel
Endo Pharmaceuticals has obtained Food and Drug Administration clearance to market Fortesta Gel for topical use to treat men with low testosterone.
Impax to market generic Doryx
Impax Laboratories Inc. has received final approval from the Food and Drug Administration for 75-mg and 100-mg doxycyline hyclate delayed-release tablets, a generic version of the antibacterial medication Doryx.
Half of Frito-Lay product lineup to be all-natural
Frito-Lay North America plans to make about 50% of its product portfolio with all-natural ingredients and has begun shipping the first natural snacks to retailers. The PepsiCo division said Tuesday that the strategy includes three of its biggest brands: Lay’s, Tostitos and SunChips.
Coty readies flurry of Sally Hansen launches
Coty Inc. is launching a wide range of Sally Hansen beauty implements and nail care products in the first quarter, including polish, polish strips, gel treatments and growth serum. The company is also rolling out new Sally Hansen hand creams, foot care products, lip treatments and a depilatory.
Sustainability strategy progresses at Nice-Pak
Nice-Pak Products Inc. has transformed its Mooresville, Ind., manufacturing plant into what it calls a “zero landfill” facility. The move, expected to keep more than 4,200 tons of waste a year from going into landfills, is the second transformation of a Nice-Pak facility in the past six months.
Cephalon names Buchi as CEO
Cephalon Inc. has appointed J. Kevin Buchi as chief executive officer and a member of the biopharmaceutical company’s board. The move comes following the death of Cephalon founder, chairman and CEO Frank Baldino Jr. earlier this month at age 57 from complications related to leukemia.
Merck’s Gardasil approved for new indications
Gardasil, Merck’s vaccine for human papillomavirus (HPV), has been approved by the Food and Drug Administration for the prevention of anal cancer and anal intraepithelial neoplasia (AIN).
Watson gets OK for novel oral contraceptive
Watson Pharmaceuticals next year plans to roll out a chewable, low-dose oral contraceptive that the company called a new option for birth control.
Novartis triple-combination pill approved for hypertension
Novartis has received approval from the Food and Drug Administration for Amturnide tablets for the treatment of high blood pressure.